Navigation Links
The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring 'Last Lecturer' Dr. Randy Pausch
Date:4/17/2008

- Long-form web-based PSA ("Life. Lessons. Legacy.") features Carnegie-Mellon Professor's fight against pancreatic cancer and underscores his call-to-action for additional research into nation's fourth leading

cancer killer - PSA debuts on heels of Lustgarten Foundation's limited online book offer as seen on ABC Primetime with Diane Sawyer, where 5,000 free copies of "The

Last Lecture" were given to the public - Short-form (:30) PSA will air on major cable and television stations,

directing viewers to long-form PSA online

- The Lustgarten Foundation is nation's largest private, non-profit supporter of pancreatic cancer research, providing more than $20 million to

date

BETHPAGE, N.Y., April 17 /PRNewswire/ -- The Lustgarten Foundation for Pancreatic Cancer Research, the nation's largest private foundation dedicated to supporting pancreatic cancer research, announced the debut of a new web- based long-form PSA featuring Dr. Randy Pausch. In the PSA, Dr. Pausch and his wife, Jai, share their thoughts about coping with a diagnosis of pancreatic cancer. Dr. Pausch speaks about the urgent need for additional research into the nation's fourth deadliest cancer and expresses concern that his children may someday face this deadly disease.

Said Dr. Robert Vizza, Lustgarten Foundation President, "Pancreatic cancer is an insidious disease because there is are no reliable tests to detect it early, when the chances for a cure are greatest. The disease is also aggressive and highly resistant to standard treatments."

Said Dr. Randy Pausch, "There have been too few advances in pancreatic cancer and, as a result, patients have limited options. For the sake of generations to come, we need to change the course of this disease. Only by giving the best and brightest scientific minds access to the resources they need will we find better treatments and, ultimately, a cure."

Said Kerri Kaplan, Lustgarten Foundation Executive Director, "The Lustgarten Foundation is committing millions of dollars for promising research precisely because the scientific method is our best hope in the fight against pancreatic cancer. We are proud to have the incredible partnership of the Pausch family, and we thank them for sharing their experience and serving as an inspiration to others."

The PSA is supported by an educational grant from Genentech and OSI Pharmaceuticals. View the PSA online at http://www.lustgarten.org/LUS/Content/CDA/ArticlesDetail.jsp?ContentId=478


'/>"/>
SOURCE The Lustgarten Foundation for Pancreatic Cancer Research
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project
2. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
3. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
4. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
5. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
6. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
7. The Parkinsons Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinsons Disease
8. Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship
9. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
10. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
11. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 20, 2017 , ... ... to the healthcare industry ( http://www.gandlscientific.com ), has announced the opening of new ... clinical and scientific consultants and contractors. This is the latest step in G&L’s ...
(Date:1/21/2017)... ... January 21, 2017 , ... Nova Oculus Partners has ... pioneering medical device for the treatment of Age-Related Macular Degeneration. , The company’s ... global regulatory consultancy that helps companies like ours secure government approvals for their ...
(Date:1/21/2017)... 20, 2017 Bioptix, Inc. (Nasdaq: ... that on January 14, 2017 the Board of Directors ... Company will terminate certain employees associated with the September ... Company commenced terminations on January 16, 2017 and terminations ... Company may pay severance benefits in certain circumstances of ...
(Date:1/21/2017)... Jan. 21, 2017   Boston Biomedical , an ... to target cancer stemness pathways, today presented data from ... at the 2017 American Society of Clinical Oncology (ASCO) ... . In a Phase Ib/II study ... to inhibit cancer stemness pathways by targeting STAT3 – ...
Breaking Biology Technology:
(Date:1/4/2017)... -- For the thousands of attendees at this year,s International Consumer Electronics Show ... biometric measurement devices and services, will be featuring its new line of ... Medical,s special CES Exhibit Suite , the new upper arm and ... WellnessConnected product platform.  Continue ... ...
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical ... 12.14 billion by 2021 from USD 5.31 billion in 2016, at ... ... mainly driven by technological advancements in medical devices, launch of a ... preference for wireless connectivity among healthcare providers, and increasing focus on ...
Breaking Biology News(10 mins):